• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAC1 GTP对肝细胞癌放疗的作用及相关机制

The effect and related mechanisms of RAC1 GTP on radiotherapy for hepatocellular carcinoma.

作者信息

Xu Xiaoyu, Fang Zhengxuying, Jiang Wei, Chou Jianbo, Lu Yi

机构信息

1Department of Oncology, The Yuyao People's Hospital, Ningbo, China; 2Department of Health Science Center, Medical College of Ningbo University, Ningbo, China; 3Department of Oncology, The Ningbo 7th People's Hospital, Ningbo, China; 4Department of Radiation Oncology, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.

出版信息

Transl Cancer Res. 2025 Jun 30;14(6):3772-3784. doi: 10.21037/tcr-2025-987. Epub 2025 Jun 27.

DOI:10.21037/tcr-2025-987
PMID:40687217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12268864/
Abstract

BACKGROUND

Ras-related C3 botulinum toxin substrate 1 (), a pivotal Rho guanosine triphosphatases (GTPase) implicated in oncogenic processes and radiotherapeutic resistance across malignancies, has not been extensively examined within the context of hepatocellular carcinoma (HCC) radiotherapy. Therefore, this study aimed to evaluate the expression and prognostic significance of RAC1 in HCC, investigate the molecular mechanisms by which radiation-induced RAC1 GTPase activity mediates radioresistance, and validate targeted inhibition of this activity as a potential strategy to enhance HCC radiosensitivity.

METHODS

expression was assessed in HCC versus adjacent tissues via The Cancer Genome Atlas (TCGA) and immunohistochemical (IHC) staining of clinical specimens. Its prognostic significance was rigorously evaluated using Cox regression models and visualized via nomogram construction. Radiation-induced RAC1 GTP activity in MHCC97-H cells was quantified by G-protein-linked immunosorbent assay (G-LISA), with downstream signaling (p-IκBα/Bcl-xL) and cell cycle dynamics analyzed via Western blotting and flow cytometry. NSC23766, a RAC1 GTP inhibitor, was employed to identify the pathway-specific effects.

RESULTS

exhibited marked overexpression in HCC tissues, correlating with advanced pathological stages and inferior prognosis. Radiation triggered RAC1 GTP activation in MHCC97-H cells, driving p-IκBα/Bcl-xL antiapoptotic signaling and G2/M arrest. NSC23766 suppressed radiation-induced IκBα phosphorylation (P<0.05), Bcl-xL upregulation, and cell cycle arrest attenuating radioresistance.

CONCLUSIONS

overexpression portends poor HCC prognosis and mediates radioresistance through GTP-dependent activation of antiapoptotic pathways and cell cycle modulation. Targeting RAC1 GTP activity may enhance the radiosensitivity of HCC.

摘要

背景

Ras相关的C3肉毒杆菌毒素底物1(RAC1)是一种关键的Rho鸟苷三磷酸酶(GTP酶),参与致癌过程和多种恶性肿瘤的放射治疗耐药性,但在肝细胞癌(HCC)放疗背景下尚未得到广泛研究。因此,本研究旨在评估RAC1在HCC中的表达及预后意义,探讨辐射诱导的RAC1 GTP酶活性介导放射抗性的分子机制,并验证靶向抑制该活性作为增强HCC放射敏感性的潜在策略。

方法

通过癌症基因组图谱(TCGA)以及临床标本的免疫组织化学(IHC)染色评估HCC组织与癌旁组织中RAC1的表达。使用Cox回归模型严格评估其预后意义,并通过列线图构建进行可视化。通过G蛋白偶联免疫吸附测定(G-LISA)定量MHCC97-H细胞中辐射诱导的RAC1 GTP活性,通过蛋白质印迹和流式细胞术分析下游信号传导(p-IκBα/Bcl-xL)和细胞周期动态。使用RAC1 GTP抑制剂NSC23766确定通路特异性效应。

结果

RAC1在HCC组织中显著过表达,与晚期病理阶段和较差的预后相关。辐射触发MHCC97-H细胞中的RAC1 GTP激活,驱动p-IκBα/Bcl-xL抗凋亡信号传导和G2/M期阻滞。NSC23766抑制辐射诱导的IκBα磷酸化(P<0.05)、Bcl-xL上调和细胞周期阻滞,减弱放射抗性。

结论

RAC1过表达预示HCC预后不良,并通过抗凋亡通路的GTP依赖性激活和细胞周期调节介导放射抗性。靶向RAC1 GTP活性可能增强HCC的放射敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/050ddd4601b0/tcr-14-06-3772-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/391ecea61aa3/tcr-14-06-3772-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/8b40c4dd788f/tcr-14-06-3772-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/eec3473f975e/tcr-14-06-3772-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/061b271c3249/tcr-14-06-3772-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/5a87132d8484/tcr-14-06-3772-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/050ddd4601b0/tcr-14-06-3772-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/391ecea61aa3/tcr-14-06-3772-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/8b40c4dd788f/tcr-14-06-3772-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/eec3473f975e/tcr-14-06-3772-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/061b271c3249/tcr-14-06-3772-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/5a87132d8484/tcr-14-06-3772-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24b4/12268864/050ddd4601b0/tcr-14-06-3772-f6.jpg

相似文献

1
The effect and related mechanisms of RAC1 GTP on radiotherapy for hepatocellular carcinoma.RAC1 GTP对肝细胞癌放疗的作用及相关机制
Transl Cancer Res. 2025 Jun 30;14(6):3772-3784. doi: 10.21037/tcr-2025-987. Epub 2025 Jun 27.
2
Integrated network pharmacology and experimental validation reveal EGFR/p53/Bcl-2-mediated anti-hepatocellular carcinoma effects of Zedoary Turmeric Oil.整合网络药理学与实验验证揭示莪术油通过EGFR/p53/Bcl-2介导的抗肝癌作用
J Ethnopharmacol. 2025 Jul 3;352:120241. doi: 10.1016/j.jep.2025.120241.
3
The role of JPT1 in hepatocellular carcinoma: tumor progression, microtubule dynamics regulation, and potential mechanisms within the immune microenvironment.JPT1在肝细胞癌中的作用:肿瘤进展、微管动力学调节及免疫微环境中的潜在机制
Discov Oncol. 2025 Jul 3;16(1):1258. doi: 10.1007/s12672-025-03066-1.
4
The molecular sub-type and the development and validation of a prognosis prediction model based on endocytosis-related genes for hepatocellular carcinoma.基于内吞作用相关基因的肝细胞癌分子亚型及预后预测模型的构建与验证
J Gastrointest Oncol. 2025 Jun 30;16(3):1115-1126. doi: 10.21037/jgo-2025-359. Epub 2025 Jun 27.
5
Quercetin regulates sensitivity to X-ray radiation of hepatocellular carcinoma through miR-216a-3p.槲皮素通过miR-216a-3p调节肝癌细胞对X射线辐射的敏感性。
Biomol Biomed. 2025 Mar 7;25(4):833-849. doi: 10.17305/bb.2024.11125.
6
Nuclear factor IA-mediated transcriptional regulation of crystallin αB inhibits hepatocellular carcinoma progression.核因子IA介导的晶状体蛋白αB转录调控抑制肝细胞癌进展。
Mol Clin Oncol. 2025 Jun 20;23(2):72. doi: 10.3892/mco.2025.2867. eCollection 2025 Aug.
7
Exploring the mechanism of Naringenin in the treatment of hepatocellular carcinoma based on mRNA sequencing and experimental validation.基于mRNA测序和实验验证探索柚皮素治疗肝细胞癌的机制
Sci Rep. 2025 Jul 2;15(1):23109. doi: 10.1038/s41598-025-09013-y.
8
Hepatitis B virus core/capsid protein induces hepatocellular carcinoma progression via long non-coding RNA KCNQ1OT1/miR-335-5p/CDC7 axis.乙型肝炎病毒核心/衣壳蛋白通过长链非编码RNA KCNQ1OT1/miR-335-5p/CDC7轴诱导肝细胞癌进展。
Transl Cancer Res. 2025 Jun 30;14(6):3319-3335. doi: 10.21037/tcr-2025-233. Epub 2025 Jun 16.
9
Disulfidptosis-related genes RPN1 inhibits the progression of hepatocellular carcinoma by regulating cell cycle, may be a new therapeutic targets.二硫键连接的细胞焦亡相关基因RPN1通过调控细胞周期抑制肝细胞癌进展,可能是新的治疗靶点。
Inflamm Res. 2025 Jul 22;74(1):105. doi: 10.1007/s00011-025-02070-z.
10
Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.奥曲肽作为一种抗肿瘤血管生成化合物,可抑制携带人肝细胞癌异种移植瘤的裸鼠的肿瘤生长。
J Cancer Res Clin Oncol. 2003 Jun;129(6):327-34. doi: 10.1007/s00432-003-0447-5. Epub 2003 Jun 14.

本文引用的文献

1
Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1.抗癌治疗引发的甲羟戊酸途径激活通过激活 Rac-1 驱动胶质母细胞瘤复发。
Cancer Res Commun. 2024 Jun 25;4(6):1566-1580. doi: 10.1158/2767-9764.CRC-24-0049.
2
STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma.STEAP3 通过促进 EGFR 的核易位促进肝癌细胞增殖,从而增强 RAC1-ERK-STAT3 信号通路。
Cell Death Dis. 2021 Nov 5;12(11):1052. doi: 10.1038/s41419-021-04329-9.
3
Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC.
葡萄糖和心磷脂生物合成的整合赋予 HCC 辐射抗性。
Hepatology. 2022 Jun;75(6):1386-1401. doi: 10.1002/hep.32177. Epub 2021 Dec 6.
4
The RHO Family GTPases: Mechanisms of Regulation and Signaling.RHO 家族 GTPases:调节和信号转导机制。
Cells. 2021 Jul 20;10(7):1831. doi: 10.3390/cells10071831.
5
Rac1, A Potential Target for Tumor Therapy.Rac1,一种肿瘤治疗的潜在靶点。
Front Oncol. 2021 May 17;11:674426. doi: 10.3389/fonc.2021.674426. eCollection 2021.
6
Hepatocellular carcinoma.肝细胞癌
Nat Rev Dis Primers. 2021 Jan 21;7(1):7. doi: 10.1038/s41572-021-00245-6.
7
P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer.P21 激活激酶 1:癌症中新兴的生物学功能和潜在治疗靶点。
Theranostics. 2020 Aug 1;10(21):9741-9766. doi: 10.7150/thno.46913. eCollection 2020.
8
Rho GTPases in cancer radiotherapy and metastasis.Rho GTP酶在癌症放射治疗与转移中的作用
Cancer Metastasis Rev. 2020 Dec;39(4):1245-1262. doi: 10.1007/s10555-020-09923-5. Epub 2020 Aug 8.
9
CAMSAP2-mediated noncentrosomal microtubule acetylation drives hepatocellular carcinoma metastasis.CAMSAP2 介导的非中心体微管乙酰化驱动肝癌转移。
Theranostics. 2020 Feb 19;10(8):3749-3766. doi: 10.7150/thno.42596. eCollection 2020.
10
miR-506 regulates cell proliferation and apoptosis by affecting RhoA/ROCK signaling pathway in hepatocellular carcinoma cells.微小RNA-506通过影响肝癌细胞中的RhoA/ROCK信号通路来调节细胞增殖和凋亡。
Int J Clin Exp Pathol. 2019 Apr 1;12(4):1163-1173. eCollection 2019.